0 Items
+1.855.816.PALS (7257) [email protected]
Awaiting product image
FSA and HSA eligible

Metoprolol Tartrate (Immediate Release) 100 mg Tablets — Generic For Lopressor — TruPharma

$6.99 - or Auto-Reorder and Save 5%

Need A Prescription?See A Prescriber.

Metoprolol Tartrate (Immediate Release) 100 mg Tablets — Generic For Lopressor — TruPharma is available through Pill Pals Pharmacy with cash-pay pharmacy pricing and free shipping where available. Prescription required.

Prescription Transfer Available
Need to transfer your prescription?

Request a prescription transfer and our pharmacy team will help coordinate the next step.

Request Prescription Transfer

Do you need this exact manufacturer? Check the box below.

Important: Manufacturer availability may vary due to shortages, recalls, wholesaler inventory, prescription requirements, and applicable laws.

Pill Pals will make a reasonable effort, but the same manufacturer cannot be guaranteed every time. Patients should not stop, change, or switch medications without speaking with their pharmacist or prescriber.

Select Delivery Options:

SKU: 52817-0254-10-30p Categories: , Brand:

Shop with Confidence at Pill Pals® - We're The EXPRESS Pharmacy

Secured by Sectigo SSL Certificate

Secure checkout, SSL protection, and trusted shopping safeguards for Pill Pals® customers.

Description

pill pass picture pill pals

prescription required

Metoprolol Tartrate (Immediate Release) 100 mg Tablets is available by prescription only. Go ahead and place your purchase. After making payment, we will ensure that a valid prescription is received from your prescriber.

Drug Label Highlights

Source: This information is taken from the official DailyMed drug label page when available. It is provided for educational purposes and is not a substitute for pharmacist counseling, prescriber instructions, or the full official labeling.

These highlights do not include all the information needed to use METOPROLOL TARTRATE TABLETS safely and effectively. See full prescribing information for METOPROLOL TARTRATE TABLETS.

METOPROLOL TARTRATE tablets, for oral use

Initial U.S. Approval: 1992

Indications And Usage

Metoprolol tartrate is a beta-adrenergic blocker indicated for the treatment of:

Hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and non-fatal cardiovascular events, primarily strokes and myocardial infarctions. (

1.1)

Angina Pectoris. (

1.2)

Myocardial Infarction, to reduce the risk of cardiovascular mortality when used in conjunction with intravenous metoprolol therapy in patients with definite or suspected acute myocardial infarction in hemodynamically stable patients. (

1.3)

Dosage And Administration

Administer once daily with food or after a meal. Titrate at weekly or longer intervals as needed and tolerated. (

2)

Hypertension: Recommended starting dosage is 100 mg daily, in single or divided doses. (

2.1)

Angina Pectoris: Recommended starting dosage is 100 mg daily, given as two divided doses. (

2.2)

Myocardial Infarction: The starting dosage depends upon tolerance of intravenous metoprolol, see full prescribing information. (

2.3)

Dosage Forms And Strengths

Metoprolol tartrate tablets: 25 mg, 37.5 mg, 50 mg, 75 mg or 100 mg. (

3)

Contraindications

Known hypersensitivity to product components. (

4)

Severe bradycardia: Greater than first degree heart block, or sick sinus syndrome without a pacemaker. (

4)

Cardiogenic shock or decompensated heart failure. (

4)

Warnings And Precautions

  • Abrupt cessation may exacerbate myocardial ischemia. ( 5.1)
  • Heart Failure: Worsening cardiac failure may occur. ( 5.2)
  • Bronchospastic Disease: Avoid beta-blockers. ( 5.3)
  • Pheochromocytoma: Initiate therapy with an alpha blocker. ( 5.4)
  • Major Surgery: Avoid initiation of high-dose extended-release metoprolol in patients undergoing non- cardiac surgery. Do not routinely withdraw chronic beta-blocker therapy prior to surgery. ( 5.5, 6.1)
  • Diabetes: May mask symptoms of hypoglycemia. ( 5.6)
  • Thyrotoxicosis: Abrupt withdrawal in patients with thyrotoxicosis might precipitate a thyroid storm. ( 5.7)
  • Peripheral Vascular Disease: Can aggravate symptoms of arterial insufficiency. ( 5.9)
  • Abrupt cessation may exacerbate myocardial ischemia. ( 5.1)
  • Heart Failure: Worsening cardiac failure may occur. ( 5.2)
  • Bronchospastic Disease: Avoid beta-blockers. ( 5.3)
  • Pheochromocytoma: Initiate therapy with an alpha blocker. ( 5.4)
  • Major Surgery: Avoid initiation of high-dose extended-release metoprolol in patients undergoing non- cardiac surgery. Do not routinely withdraw chronic beta-blocker therapy prior to surgery. ( 5.5, 6.1)
  • Diabetes: May mask symptoms of hypoglycemia. ( 5.6)
  • Thyrotoxicosis: Abrupt withdrawal in patients with thyrotoxicosis might precipitate a thyroid storm. ( 5.7)
  • Peripheral Vascular Disease: Can aggravate symptoms of arterial insufficiency. ( 5.9)

Abrupt cessation may exacerbate myocardial ischemia. (

5.1)

Heart Failure: Worsening cardiac failure may occur. (

5.2)

Bronchospastic Disease: Avoid beta-blockers. (

5.3)

Pheochromocytoma: Initiate therapy with an alpha blocker. (

5.4)

Major Surgery: Avoid initiation of high-dose extended-release metoprolol in patients undergoing non- cardiac surgery. Do not routinely withdraw chronic beta-blocker therapy prior to surgery. (

5.5,

6.1)

Diabetes: May mask symptoms of hypoglycemia. (

5.6)

Thyrotoxicosis: Abrupt withdrawal in patients with thyrotoxicosis might precipitate a thyroid storm. (

5.7)

Peripheral Vascular Disease: Can aggravate symptoms of arterial insufficiency. (

5.9)

Adverse Reactions

Most common adverse reactions: tiredness, dizziness, depression, shortness of breath, bradycardia, hypotension, diarrhea, pruritus, rash. (

6.1)

To report SUSPECTED ADVERSE REACTIONS, contact TruPharma, LLC at (877) 541-5504 or FDA at 1-800-FDA-1088 or

www.fda.gov/medwatch.

Drug Interactions

Catecholamine-depleting drugs may have an additive effect when given with beta-blocking agents. (

7.1)

Patients may be unresponsive to the usual doses of epinephrine used to treat allergic reaction. (

7.2)

CYP2D6 Inhibitors are likely to increase metoprolol concentration. (

7.3)

Concomitant use of glycosides, clonidine, and diltiazem and verapamil with beta-blockers can increase the risk of bradycardia. (

7.4)

Beta-blockers including metoprolol, may exacerbate the rebound hypertension that can follow the withdrawal of clonidine. (

7.4)

Use In Specific Populations

Hepatic Impairment: Consider initiating Metoprolol tartrate therapy at low doses and gradually increase dosage to optimize therapy, while monitoring closely for adverse events. (

8.6)

See 17 for PATIENT COUNSELING INFORMATION.

Revised: 8/2024

View Full DailyMed Label View DailyMed PDF

DailyMed highlights last updated: 2026-06-24 22:43:21

Additional information

Size/Count

30 Count
Dose/Strength

100 MG
Form

Tablet

Medication Guide

Official DailyMed Drug Label Information

This product has a DailyMed drug label PDF from the National Library of Medicine.

View / Download PDF View on DailyMed

  • Source: DailyMed, National Library of Medicine
  • DailyMed Label: METOPROLOL TARTRATE TABLET [TRUPHARMA LLC]
  • Matched NDC: 52817-254-10
  • Published Date: Sep 20, 2024

Medication Summary

Medication Summary: This section summarizes DailyMed drug label information to make the label easier to understand. It is not a substitute for the official label, pharmacist counseling, prescriber instructions, or medical advice.

Overview

Metoprolol tartrate tablets are a beta-blocker taken by mouth. The label says they are used to treat high blood pressure, long-term angina, and certain hemodynamically stable patients with definite or suspected acute myocardial infarction.

For hypertension, lowering blood pressure can reduce the risk of strokes and heart attacks. For angina, the medicine is used to reduce angina attacks and improve exercise tolerance. For myocardial infarction, it is used to reduce cardiovascular mortality when used alone or with intravenous metoprolol.

The tablets are intended to be taken once daily with food or after a meal, and dosing is adjusted based on response and tolerance. The label also lists important warnings, including not stopping the medicine suddenly, because abrupt cessation may worsen heart-related symptoms.

Storage Information

store clinical stability before advancing the dose of Metoprolol tartrate [see Dosage and Administration (2)]. STORAGE AND HANDLING Metoprolol Tartrate Tablets, USP are available containing 25 mg, 37. Storage: Store at 20° to 25°C (68° to 77°F). Dispense in a tight, light-resistant container (USP) as defined in the USP using a child-resistant closure.

Key Counseling Points

  • Take metoprolol tartrate once daily with food or after a meal, as directed on your prescription.
  • Do not stop taking this medicine suddenly; the label warns that abrupt cessation may worsen angina or lead to other heart problems.
  • If you have been told to taper off therapy, the dose should be reduced gradually over 1 to 2 weeks.
  • The label says this medicine may cause tiredness, dizziness, depression, shortness of breath, bradycardia, hypotension, diarrhea, pruritus, or rash.
  • This medicine may mask early warning signs of hypoglycemia, such as tachycardia.
  • Tell a healthcare professional if you have bronchospastic disease, heart failure, diabetes, thyrotoxicosis, peripheral vascular disease, or a history of severe allergic reactions, because the label includes special warnings for these conditions.
  • The label states that CYP2D6 inhibitors may increase metoprolol concentration.
  • Concomitant use with digitalis glycosides, clonidine, diltiazem, or verapamil can increase the risk of bradycardia.
  • For myocardial infarction use, the label gives specific dosing based on tolerance of intravenous metoprolol; follow the prescribed regimen exactly.

Helpful Patient Education

Metoprolol tartrate tablets are an oral beta-adrenergic blocker used for the treatment of hypertension, angina pectoris, and certain patients with acute myocardial infarction. The label describes once-daily administration with food or after a meal, with dose adjustments made at weekly or longer intervals as needed and tolerated.

This product labeling also highlights key safety information, including contraindications such as severe bradycardia, certain heart block conditions, cardiogenic shock, decompensated heart failure, and hypersensitivity to product components. Common adverse reactions listed in the label include tiredness, dizziness, depression, shortness of breath, bradycardia, hypotension, diarrhea, pruritus, and rash.

Medication Summary last generated: 2026-07-19 02:43:31

Metoprolol Tartrate (Immediate Release) 100 mg Tablets --- Generic For Lopressor --- TruPharma may require patient-specific counseling based on your prescription, directions, allergies, medical history, and other medications.

This Medication Guide section is provided for general educational purposes only. It does not replace the official medication guide, patient information leaflet, counseling from your pharmacist, or medical advice from your prescriber.

Please read all information provided with your prescription. Contact Pill Pals Pharmacy or your prescriber with questions before using this medication.

Pill Pals Pharmacy counseling service

Reviews

There are no reviews yet.

Only logged in customers who have purchased this product may leave a review.

Related products